TAP Biosystems Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TAP Biosystems Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12344
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a provider of laboratory and pharmaceutical equipment. The company designs and manufactures automated cell culture, bio-reactor systems and fermentation systems. It also provides labware, consumables and accessories. TAP offers services such as installation, onsite repair services, preventative maintenance, operator and maintenance training, system and software upgrades, preventive maintenance visits, lab relocations and decommissioning, protocol development, customer support, and validation and GMP compliance. The company’s products find application in drug discovery, biologics production, bioprocess development, regenerative medicine and tissue engineering. It partners with distribution companies. It has operations in Royston, the UK; and Wilmington, the US. TAP is headquartered in Royston, the UK.

TAP Biosystems Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TAP Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 11
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 12
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 13
TAP Biosystems Enters Into Co-Development Agreement With University College London 14
TAP Biosystems Enters Into Co-Development Agreement With Open University 15
Licensing Agreements 16
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 16
Acquisition 17
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 17
TAP Biosystems Ltd – Key Competitors 19
TAP Biosystems Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Key Facts 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAP Biosystems Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
TAP Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 11
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 12
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 13
TAP Biosystems Enters Into Co-Development Agreement With University College London 14
TAP Biosystems Enters Into Co-Development Agreement With Open University 15
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 16
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 17
TAP Biosystems Ltd, Key Competitors 19
TAP Biosystems Ltd, Other Locations 20

List of Figures
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TAP Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TAP Biosystems Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cimab SA-製薬・医療分野:企業M&A・提携分析
    Summary Cimab SA (Cimab) is a biopharmaceutical company that develops and markets monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer and other diseases related to the immune system. The company offers products such as cimaher nimotuzumab, ior epocim epoeti …
  • Toa Corp (1885):企業の財務・戦略的SWOT分析
    Toa Corp (1885) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Toyo Engineering Corp:企業の戦略・SWOT・財務分析
    Toyo Engineering Corp - Strategy, SWOT and Corporate Finance Report Summary Toyo Engineering Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • RRB Energy Ltd:企業の戦略的SWOT分析
    RRB Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Span Diagnostics Ltd (524727)-医療機器分野:企業M&A・提携分析
    Summary Span Diagnostics Ltd (SPAN) is a medical equipment company that develops and manufactures diagnostic products for healthcare markets. The company’s products include reagents, antibiotic disc and instruments. It offers reagents such as glucose, microprotein, amylase, calcium, chloride, uric a …
  • Versum Materials, Inc.:企業の戦略的SWOT分析
    Versum Materials, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Foundation Medicine Inc (FMI):製薬・医療:M&Aディール及び事業提携情報
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne …
  • Karlsruhe Institute of Technology-製薬・医療分野:企業M&A・提携分析
    Summary Karlsruhe Institute of Technology (KIT) is an educational institute that offers research based scientific education. The institute offers research programs in the areas of biology, chemistry, and process engineering; mechanical and electrical engineering; physics and mathematics; natural and …
  • Eco (Atlantic) Oil & Gas Ltd (EOG):企業の財務・戦略的SWOT分析
    Summary Eco (Atlantic) Oil & Gas Ltd (Eco) is an oil and gas exploration and development company. The company’s business activities include acquisition, identification, and development of upstream petroleum projects across Africa. The company's projects include cooper license-PEL 030, Sharon license …
  • Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析
    Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Great Eastern Energy Corp Ltd (GEEC):企業の財務・戦略的SWOT分析
    Summary Great Eastern Energy Corp Ltd (GEECL), a subsidiary of YKM Holdings Pvt Ltd, is an oil and gas exploration and production company. The company carries out extraction and sale of coal bed methane coalbed methane gas. It operates upstream, midstream and downstream projects in Raniganj south bl …
  • Arabian Shield Cooperative Insurance Company:企業の戦略・SWOT・財務情報
    Arabian Shield Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Arabian Shield Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Oceanteam ASA (OTS):企業の財務・戦略的SWOT分析
    Oceanteam ASA (OTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • SEGRO Plc:企業のM&A・事業提携・投資動向
    SEGRO Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SEGRO Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Novita Healthcare Ltd (NHL)-製薬・医療分野:企業M&A・提携分析
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) operates as a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents …
  • Angel Yeast Co Ltd:企業の戦略・SWOT・財務情報
    Angel Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Angel Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Thales SA:企業のM&A・事業提携・投資動向
    Thales SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Thales SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆